CMO eyes clinical trials; BearingPoint, Bovis Lend Lease target Emerald Isle;

> New York contract manufacturer Norwich Pharmaceuticals has invested in the infrastructure, controls and specialized equipment necessary for pilot-scale formulation and the manufacture of clinical trial materials. Announcement

> Tech consultancy BearingPoint and construction management company Bovis Lend Lease have teamed to support the pharmaceutical and medical technology sectors in Ireland. Release

> Shanghai-based WuXi PharmaTech has named Wei-Min Chang has been appointed Vice President of Operations and General Manager of the company's SynTheAll manufacturing facility, where it makes active pharmaceutical ingredients and advanced intermediates for use in preclinical and clinical trials. The company recently completed construction of an expanded facility, known as SynTheAll Phase 2, to produce advanced intermediates and APIs for late-stage clinical trials and commercial supplies. Release

> A mid- to high-level production double-sided tablet press boasts 49 stations, touch-screen controls, automatic weight control and removable turret capabilities. Article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.